| Matrin-3 Protein | |
|---|---|
| Gene | MATR3 |
| UniProt | P43243 |
| PDB | 5D99 |
| Mol. Weight | 125 kDa |
| Localization | Nuclear matrix, speckles |
| Family | Matrin-3 family, RNA-binding |
| Diseases | ALS, FTD, Parkinson's Disease |
Matrin-3 is a nuclear matrix protein with dual roles as an RNA-binding protein and DNA-binding transcription factor[^1]. Mutations in MATR3 are causally linked to familial amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), establishing it as an important disease protein in neurodegeneration[^2].
The MATR3 gene encodes a protein of approximately 847 amino acids that is ubiquitously expressed but with highest levels in skeletal muscle and neuronal tissues. Matrin-3 is a core component of the nuclear matrix, the structural framework that organizes the nucleus[^3].
Matrin-3 contains multiple functional domains:
Two RNA recognition motifs (RRM1 and RRM2) in the central region mediate RNA binding. These domains are highly conserved and recognize specific RNA sequences.
Multiple C2H2-type zinc-finger domains in the C-terminal region mediate DNA binding and protein-protein interactions.
NLS sequences direct Matrin-3 to the nuclear compartment.
A glycine-rich domain facilitates protein-protein interactions[^4].
Matrin-3 is a principal component of the nuclear matrix:
As an RNA-binding protein, Matrin-3 participates in:
Matrin-3 functions as a transcriptional co-regulator:
Dominant mutations in MATR3 cause familial ALS, typically with a late onset and predominantly upper motor neuron involvement. Notable mutations include:
The pathogenic mechanisms include:
MATR3 mutations also cause FTD, often with overlapping clinical features with ALS. TDP-43 pathology is commonly observed in MATR3-associated FTD[^7].
Matrin-3 interacts with proteins implicated in PD pathogenesis, including:
Dysregulation of Matrin-3 function may contribute to dopaminergic neuron vulnerability[^8].
Current therapeutic approaches include: